Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -361.9% | +9.1% | 2 / 3 | -26.5% | -8.88 pp | -2.48 pp | +8.2% | 0.12 | 22.83 | 86,7 | −26,5% | −1,7 | −361,9% | 22.83 | 34.72 | −34,2% |
| Pts | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 75.800 (close price on 2026-10-16)EPS (TTM): 3.320
Financial charts
1.Revenue & growth
VND bn86,7Q2/26
1.Revenue & growth
VND bn86,7Q2/26
2.Profit & growth
VND bn-1,68Q2/26
3.Profit mix (Penman)
VND bn68,9Q2/26
4.Margins & cost structure
%21.5%Q2/26
5.Returns & cash cycle
% · days3.9%Q2/26
6.Earnings quality & cash
VND bn-116Q2/26
7.Asset structure
VND bn837Q2/26
8.Funding & debt health
VND bn · times837Q2/26
9.Revenue backlog
VND bn11,9Q2/26
10.Valuation
times · %22,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-102Q2/26
Adjusted EPS growth, latest quarter
-362%
Average adjusted EPS growth, 3 quarters
9.1%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26